Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · IEX Real-Time Price · USD
1.460
+0.060 (4.29%)
At close: Apr 18, 2024, 4:00 PM
1.440
-0.020 (-1.37%)
Pre-market: Apr 19, 2024, 8:11 AM EDT
PACB Stock Forecast
PACB's stock price has decreased by -86.59% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 11 analysts with 12-month price forecasts for PACB stock have an average target of 7.77, with a low estimate of 2.50 and a high estimate of 15. The average target predicts an increase of 432.19% from the current stock price of 1.46.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PACB stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 5 | 6 | 6 | 5 | 5 | 4 |
| Hold | 3 | 5 | 5 | 5 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 13 | 13 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Maintains $9 → $2.5 | Buy | Maintains | $9 → $2.5 | +71.23% | Apr 18, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $7 → $2.5 | Strong Buy → Hold | Downgrades | $7 → $2.5 | +71.23% | Apr 18, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $15 → $8 | Buy | Maintains | $15 → $8 | +447.95% | Apr 18, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $12 → $2.5 | Strong Buy | Maintains | $12 → $2.5 | +71.23% | Apr 17, 2024 |
| Barclays | Barclays | Hold Maintains $8 → $3 | Hold | Maintains | $8 → $3 | +105.48% | Apr 10, 2024 |
Financial Forecast
Revenue This Year
243.60M
from 200.52M
Increased by 21.48%
Revenue Next Year
354.55M
from 243.60M
Increased by 45.55%
EPS This Year
-1.05
from -1.21
EPS Next Year
-0.87
from -1.05
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 256.9M | 414.8M | 562.2M | 816.6M | 1.0B |
| Avg | 243.6M | 354.6M | 489.9M | 749.4M | 927.9M |
| Low | 224.9M | 293.0M | 346.9M | 677.9M | 813.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 28.1% | 70.3% | 58.6% | 66.7% | 38.6% |
| Avg | 21.5% | 45.5% | 38.2% | 53.0% | 23.8% |
| Low | 12.2% | 20.3% | -2.2% | 38.4% | 8.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.98 | -0.71 | -0.34 | -0.05 | 0.35 |
| Avg | -1.05 | -0.87 | -0.54 | -0.05 | 0.34 |
| Low | -1.08 | -1.08 | -0.88 | -0.05 | 0.32 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.